Files and links (1)
Published, Version of Record (VoR)Open Access via Drexel Libraries Read and Publish Program 2025CC BY V4.0, Open
Journal article
Affinity-based controlled release of interleukin-4 from scaffolds via biotin-streptavidin interactions for immunomodulation
Journal of controlled release, v 384, 113943
10 Aug 2025
PMID: 40499762
Featured in Collection : Research Supported by Drexel Libraries' OA Programs
Abstract
Immunomodulatory cytokines like interleukin-4 (IL-4) can modulate host immune cell behavior to improve tissue integration, but versatile strategies for modifying complex biomaterials to control the release of such cytokines are limited. Bioconjugation strategies using biotin-avidin interactions offer a promising approach since biotin can be conjugated to proteins, biomaterials, and even cells, without compromising their function. Although it is known that conjugation of biotin to large biomolecules reduces its binding affinity for avidin and avidin variants, the potential to control the release of biotinylated molecules by leveraging these changes in affinity interactions has not been thoroughly investigated. Moreover, the effects of biotin and avidin variants on innate immunity are poorly understood. Therefore, the goals of this study were to determine if biotin-avidin interactions could be manipulated to control the release of IL-4 from biomaterials and to investigate the subsequent effects on primary human macrophage phenotype. First, we characterized the effects of soluble biotin, avidin, and avidin variants, streptavidin and CaptAvidin, on the phenotype of primary human macrophages from 8 different donors using RNA sequencing, finding that CaptAvidin influenced macrophage gene expression much more than the other variants. Then, after evaluating how bioconjugation parameters influenced biotin density and avidin variant binding to porous gelatin scaffolds, we found that biotin-avidin affinity interactions sustained the release of biotinylated IL-4 (bIL-4) from biotinylated and desthiobiotinylated scaffolds bound with either avidin or streptavidin for up to 14 days in vitro. Finally, we measured the response of primary human macrophages from 5 donors to the bIL-4-releasing scaffolds, finding an increase in reparative macrophage phenotype gene expression when bIL-4 was released via biotin-streptavidin interactions compared to scaffolds that relied solely on desorption-based release. These results highlight how biotin-streptavidin interactions can be leveraged for controlled release to achieve an immunomodulatory drug delivery system.
Metrics
6 Record Views
Details
- Title
- Affinity-based controlled release of interleukin-4 from scaffolds via biotin-streptavidin interactions for immunomodulation
- Creators
- Victoria A Nash - Drexel UniversityJuan F Cortes-Troncoso - Drexel UniversityPhoebe E Chua - Drexel UniversityKara L Spiller (Corresponding Author) - Drexel University
- Publication Details
- Journal of controlled release, v 384, 113943
- Publisher
- Elsevier
- Number of pages
- 13
- Grant note
- National Science Foundation: NSF CAREER 1750788
This work was supported by the National Institutes of Health (R01 HL130037 to KLS) and the National Science Foundation (NSF CAREER 1750788 to KLS) .
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- School of Biomedical Engineering, Science, and Health Systems; Chemical and Biological Engineering
- Web of Science ID
- WOS:001517116700001
- Scopus ID
- 2-s2.0-105008315127
- Other Identifier
- 991022057838904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Chemistry, Multidisciplinary
- Pharmacology & Pharmacy